Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,527,595
+$4,934,873 QoQ
Shares Held
370,208
0.0% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BAKER BROS. ADVISORS LP holds $16,600,149,582 across 76 Biotechnology names. XENE ranks #46 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,744,412 | $2,893,664,057 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,799,053 | $2,613,054,769 | |
| 3 | INSM |
INSMED Inc
|
7,421,111 | $1,213,500,070 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,141,701 | $1,121,116,222 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,896,690 | $954,880,319 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
9,555,357 | $929,258,468 | |
| 7 | CELC |
Celcuity Inc.
|
7,915,792 | $903,508,498 | |
| 8 | KOD |
Kodiak Sciences Inc.
|
19,919,186 | $759,319,370 |
All Filings in XENE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,527,595 | 370,208 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $16,592,722 | 370,208 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,863,851 | 370,208 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,587,510 | 370,208 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,655,538 | 347,408 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $38,952,216 | 993,679 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $39,121,142 | 993,679 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $38,743,544 | 993,679 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $42,777,880 | 993,679 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $45,768,854 | 993,679 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,675,988 | 751,639 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $28,938,101 | 751,639 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $26,901,159 | 751,639 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $29,637,125 | 751,639 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $27,134,167 | 751,639 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $22,864,858 | 751,639 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,977,604 | 751,639 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,481,202 | 751,639 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,485,043 | 751,639 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $13,995,518 | 751,639 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,454,338 | 751,639 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $10,571,996 | 687,386 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,416,609 | 760,308 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $10,020,739 | 799,102 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||